Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 236 | 3 | PROSTATE CANCER//PROSTATIC NEOPLASMS//UROL | 47933 |
| 282 | 2 | PROSTATE CANCER//PROSTATE//ANDROGEN RECEPTOR | 19095 |
| 8738 | 1 | ESTRAMUSTINE//ESTRAMUSTINE PHOSPHATE//HORMONE REFRACTORY PROSTATE CANCER | 1252 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | ESTRAMUSTINE | authKW | 1777500 | 8% | 72% | 98 |
| 2 | ESTRAMUSTINE PHOSPHATE | authKW | 501850 | 3% | 55% | 36 |
| 3 | HORMONE REFRACTORY PROSTATE CANCER | authKW | 500580 | 5% | 30% | 66 |
| 4 | ESTRAMUSTINE BINDING PROTEIN | authKW | 462522 | 2% | 88% | 21 |
| 5 | HORMONE REFRACTORY | authKW | 324857 | 4% | 26% | 49 |
| 6 | HRPC | authKW | 101935 | 1% | 45% | 9 |
| 7 | ESTROMUSTINE | authKW | 100686 | 0% | 100% | 4 |
| 8 | ANTIANDROGEN WITHDRAWAL | authKW | 100682 | 0% | 67% | 6 |
| 9 | HORMONE REFRACTORY PROSTATE CARCINOMA | authKW | 94871 | 1% | 54% | 7 |
| 10 | PROSTATE CANCER HORMONE REFRACTORY | authKW | 89896 | 0% | 71% | 5 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Urology & Nephrology | 19755 | 37% | 0% | 458 |
| 2 | Oncology | 12219 | 51% | 0% | 641 |
| 3 | Endocrinology & Metabolism | 161 | 6% | 0% | 70 |
| 4 | Pharmacology & Pharmacy | 92 | 8% | 0% | 96 |
| 5 | Andrology | 40 | 0% | 0% | 5 |
| 6 | Medicine, General & Internal | 13 | 3% | 0% | 42 |
| 7 | Medicine, Research & Experimental | 1 | 2% | 0% | 20 |
| 8 | Geriatrics & Gerontology | 0 | 0% | 0% | 5 |
| 9 | Primary Health Care | 0 | 0% | 0% | 2 |
| 10 | Microscopy | 0 | 0% | 0% | 2 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | ADULT ON ANK GENITOURINARY ONCOL | 37754 | 0% | 50% | 3 |
| 2 | GENITOURINARY MED ONCOL UNIT | 33561 | 0% | 67% | 2 |
| 3 | ADV PROTEOMICS | 25172 | 0% | 100% | 1 |
| 4 | AZIENDA OSPED LUIGI | 25172 | 0% | 100% | 1 |
| 5 | BETH ISRAEL DEACONESS MED BIOMETR | 25172 | 0% | 100% | 1 |
| 6 | BIOANAL ISOTOPE CHEM PHARMACOKINET | 25172 | 0% | 100% | 1 |
| 7 | BIOSTAT COMMUNITY BIOL | 25172 | 0% | 100% | 1 |
| 8 | BIOSTAT DATA MANAGEMENT SECT NIH CLIN SCI | 25172 | 0% | 100% | 1 |
| 9 | CAN LEUKEMIA GRP | 25172 | 0% | 100% | 1 |
| 10 | CANADIAN UROL ONCOL GRP | 25172 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | PROSTATE | 16366 | 4% | 1% | 55 |
| 2 | SEMINARS IN ONCOLOGY | 15090 | 4% | 1% | 56 |
| 3 | UROLOGY | 10617 | 7% | 1% | 84 |
| 4 | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 7936 | 3% | 1% | 36 |
| 5 | CANCER | 6147 | 7% | 0% | 83 |
| 6 | EUROPEAN UROLOGY | 5729 | 3% | 1% | 41 |
| 7 | UROLOGIC ONCOLOGY | 5711 | 0% | 5% | 5 |
| 8 | EUROPEAN UROLOGY SUPPLEMENTS | 4240 | 1% | 2% | 10 |
| 9 | BRITISH JOURNAL OF UROLOGY | 3242 | 2% | 0% | 28 |
| 10 | JOURNAL OF UROLOGY | 2951 | 5% | 0% | 58 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |